Follow
Yaron Rotman
Yaron Rotman
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease
Y Rotman, C Koh, JM Zmuda, DE Kleiner, TJ Liang
Hepatology 52 (3), 894-903, 2010
4712010
Emerging trends in hepatocellular carcinoma incidence and mortality
B Njei, Y Rotman, I Ditah, JK Lim
Hepatology 61 (1), 191-199, 2015
4662015
Responses of auditory-cortex neurons to structural features of natural sounds
I Nelken, Y Rotman, OB Yosef
Nature 397 (6715), 154-157, 1999
3721999
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Y Rotman, AJ Sanyal
Gut 66 (1), 180-190, 2017
3482017
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa–dependent manner
G Ahlenstiel, RH Titerence, C Koh, B Edlich, JJ Feld, Y Rotman, ...
Gastroenterology 138 (1), 325-335. e2, 2010
3062010
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
E Thomas, VD Gonzalez, Q Li, AA Modi, W Chen, M Noureddin, Y Rotman, ...
Gastroenterology 142 (4), 978-988, 2012
2872012
Kidney biomarkers associated with blood lead, mercury, and cadmium in premenopausal women: a prospective cohort study
AZ Pollack, SL Mumford, P Mendola, NJ Perkins, Y Rotman, ...
Journal of Toxicology and Environmental Health, Part A 78 (2), 119-131, 2015
2672015
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C
G Ahlenstiel, B Edlich, LJ Hogdal, Y Rotman, M Noureddin, JJ Feld, ...
Gastroenterology 141 (4), 1231-1239. e2, 2011
1732011
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes
Y Rotman, TJ Liang
Journal of virology 83 (15), 7366-7374, 2009
1712009
17‐beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease
Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ...
Hepatology 69 (4), 1504-1519, 2019
146*2019
Responses of neurons in cat primary auditory cortex to bird chirps: effects of temporal and spectral context
O Bar-Yosef, Y Rotman, I Nelken
Journal of Neuroscience 22 (19), 8619-8632, 2002
1412002
Ribavirin improves early responses to peginterferon through improved interferon signaling
JJ Feld, GA Lutchman, T Heller, K Hara, JK Pfeiffer, RD Leff, C Meek, ...
Gastroenterology 139 (1), 154-162. e4, 2010
1352010
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
AE O’Mara, JW Johnson, JD Linderman, RJ Brychta, S McGehee, ...
The Journal of clinical investigation 130 (5), 2209-2219, 2020
1232020
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients
B Edlich, G Ahlenstiel, AA Zabaleta, J Stoltzfus, M Noureddin, E Serti, ...
Hepatology 55 (1), 39-48, 2012
1202012
Long‐term therapy of chronic delta hepatitis with peginterferon alfa
T Heller, Y Rotman, C Koh, S Clark, V Haynes‐Williams, R Chang, ...
Alimentary pharmacology & therapeutics 40 (1), 93-104, 2014
882014
Development of a validated interferon score using NanoString technology
H Kim, AA de Jesus, SR Brooks, Y Liu, Y Huang, R VanTries, ...
Journal of Interferon & Cytokine Research 38 (4), 171-185, 2018
802018
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
JJ Feld, AA Modi, R El–Diwany, Y Rotman, E Thomas, G Ahlenstiel, ...
Gastroenterology 140 (3), 830-839. e3, 2011
752011
Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: systematic review and meta-analysis
MAT Han, O Altayar, S Hamdeh, V Takyar, Y Rotman, O Etzion, ...
Clinical Gastroenterology and Hepatology 17 (4), 616-629. e26, 2019
732019
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Y Rotman, M Noureddin, JJ Feld, J Guedj, M Witthaus, H Han, YJ Park, ...
Gut 63 (1), 161-169, 2014
652014
Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy
C Koh, T Heller, V Haynes‐Williams, K Hara, X Zhao, JJ Feld, DE Kleiner, ...
Alimentary pharmacology & therapeutics 37 (9), 887-894, 2013
652013
The system can't perform the operation now. Try again later.
Articles 1–20